AXA has announced that all resolutions presented during its annual shareholders’ meeting have been approved, marking several key changes to the composition of its board of directors.
Guillaume Faury and Ramon Fernandez had their board mandates renewed, while Ewout Steenbergen’s appointment as director—previously made through co-optation—was formally ratified. Meanwhile, Ramon de Oliveira stepped down after 16 years of distinguished service.
Antoine Gosset-Grainville, chairman of the board of directors, acknowledged de Oliveira’s contributions, noting how his expertise in financial markets and deep understanding of the US market have significantly influenced the group’s strategic decisions over the years.
Following the meeting, AXA’s board now comprises 14 members—eight women and six men—with nine classified as independent directors.
The structure of AXA’s board committees was also confirmed:
- Audit Committee: Chaired by Isabel Hudson, with members Clotilde Delbos, Ramon Fernandez, Angelien Kemna, and Ewout Steenbergen.
- Finance & Risk Committee: Chaired by Ramon Fernandez, including Clotilde Delbos, Gérald Harlin, Isabel Hudson, and Ewout Steenbergen.
- Compensation, Governance & Sustainability Committee: Chaired by Guillaume Faury, joined by Bettina Cramm, Gérald Harlin, Rachel Picard, and Marie-France Tschudin.
Shareholders also approved a dividend of €2.15 per share for the 2024 financial year. Additionally, plans to propose the renewal of CEO Thomas Buberl’s mandate as a director for another four-year term were discussed.
The shareholder update comes amid strong financial performance for AXA in 2024. The group reported an 8% increase in total gross written premiums and other revenues, reaching €110.3 billion.
Property & casualty premiums rose by 7% to €56.5 billion, with commercial lines up 6%, driven by higher volumes at AXA XL Insurance and favorable pricing across all regions. Personal lines premiums also increased by 7%, although volumes dipped in the UK, Ireland, and Germany due to profitability-focused measures. AXA XL Reinsurance posted a 10% rise, supported by favorable pricing and volume growth.
